KB103 for the Treatment of Dystrophic Epidermolysis Bullosa (DEB)

Condition:   Dystrophic Epidermolysis Bullosa Intervention:   Biological: KB103 Sponsor:   Krystal Biotech, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials